NASDAQ:KRSA
Cyclerion Therapeutics Q3 2026 Earnings Results & Report
$30.56 -1.40 (-4.38%) Closing price 11/4/2026 04:00 PM Eastern
Extended Trading
$30.34 -0.22 (-0.72%) As of 11/4/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Cyclerion Therapeutics beat analyst earnings expectations in its Q3 2026 results, released November 5, 2026 . The company reported EPS of -$3.19 versus the -$50.40 consensus estimate.
Earnings Announcement Details
Quarter Q3 2026
Report Date November 5, 2026
Time Before Market Opens
Conference Call 7:00 AM ET
Cyclerion Therapeutics EPS Results
Actual EPS -$3.19
Consensus EPS -$50.40
Beat/Miss Beat by +$47.21
One Year Ago EPS N/A
Cyclerion Therapeutics Revenue Results
Actual Revenue N/A
Expected Revenue $550 thousand
Beat/Miss N/A
YoY Revenue Growth N/A
Upcoming Earnings
Cyclerion Therapeutics' next earnings date is estimated for Wednesday, November 11, 2026, based on past reporting schedules.
Earnings Documents
Cyclerion Therapeutics Q3 2026 Earnings FAQ
Did Cyclerion Therapeutics beat earnings estimates f...